Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.918 |
High Similarity |
NPD3027 |
Phase 3 |
0.886 |
High Similarity |
NPD228 |
Approved |
0.879 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.871 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8689 |
High Similarity |
NPD2983 |
Phase 2 |
0.8689 |
High Similarity |
NPD2982 |
Phase 2 |
0.8661 |
High Similarity |
NPD1613 |
Approved |
0.8661 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8607 |
High Similarity |
NPD2981 |
Phase 2 |
0.8537 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8413 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8304 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.8235 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8049 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7967 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7937 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7899 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7857 |
Intermediate Similarity |
NPD9296 |
Approved |
0.784 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7786 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7737 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7724 |
Intermediate Similarity |
NPD1934 |
Approved |
0.771 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7671 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7669 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7568 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7556 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7537 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7537 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7519 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD968 |
Approved |
0.75 |
Intermediate Similarity |
NPD3060 |
Approved |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7481 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7466 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7466 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7463 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7458 |
Intermediate Similarity |
NPD291 |
Approved |
0.7458 |
Intermediate Similarity |
NPD940 |
Approved |
0.7458 |
Intermediate Similarity |
NPD846 |
Approved |
0.7438 |
Intermediate Similarity |
NPD290 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7385 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7377 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD9094 |
Approved |
0.7299 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7299 |
Intermediate Similarity |
NPD943 |
Approved |
0.728 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7279 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7258 |
Intermediate Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.7252 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7248 |
Intermediate Similarity |
NPD37 |
Approved |
0.7244 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7214 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7185 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7179 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7177 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7132 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7111 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7109 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2977 |
Approved |
0.708 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7054 |
Intermediate Similarity |
NPD111 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD7472 |
Approved |
0.704 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7034 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7032 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7025 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7021 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7021 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7014 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7008 |
Intermediate Similarity |
NPD9377 |
Approved |
0.7008 |
Intermediate Similarity |
NPD9379 |
Approved |
0.7 |
Intermediate Similarity |
NPD447 |
Suspended |
0.6993 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD709 |
Approved |
0.697 |
Remote Similarity |
NPD9381 |
Approved |
0.697 |
Remote Similarity |
NPD9384 |
Approved |
0.697 |
Remote Similarity |
NPD5846 |
Approved |
0.697 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6963 |
Remote Similarity |
NPD1283 |
Approved |
0.6962 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6957 |
Remote Similarity |
NPD9295 |
Approved |
0.6948 |
Remote Similarity |
NPD4055 |
Discovery |
0.6947 |
Remote Similarity |
NPD1182 |
Approved |
0.6944 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD1608 |
Approved |
0.6933 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6918 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6917 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6905 |
Remote Similarity |
NPD556 |
Approved |
0.6901 |
Remote Similarity |
NPD6895 |
Approved |
0.6901 |
Remote Similarity |
NPD6896 |
Approved |
0.6899 |
Remote Similarity |
NPD9299 |
Approved |
0.6897 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD1651 |
Approved |
0.6894 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD1424 |
Approved |
0.6892 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6892 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6889 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6889 |
Remote Similarity |
NPD1669 |
Approved |
0.6889 |
Remote Similarity |
NPD9622 |
Approved |
0.6887 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD4606 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD5535 |
Approved |
0.6875 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6875 |
Remote Similarity |
NPD821 |
Approved |
0.6875 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.687 |
Remote Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD1535 |
Discovery |
0.6857 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD5588 |
Approved |
0.6853 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6852 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6849 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6849 |
Remote Similarity |
NPD3750 |
Approved |
0.6849 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6846 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2668 |
Approved |
0.6842 |
Remote Similarity |
NPD4626 |
Approved |
0.6842 |
Remote Similarity |
NPD2667 |
Approved |
0.6838 |
Remote Similarity |
NPD8651 |
Approved |
0.6838 |
Remote Similarity |
NPD9365 |
Approved |
0.6829 |
Remote Similarity |
NPD8053 |
Approved |
0.6829 |
Remote Similarity |
NPD8054 |
Approved |
0.6824 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6824 |
Remote Similarity |
NPD6799 |
Approved |
0.6815 |
Remote Similarity |
NPD2233 |
Approved |
0.6815 |
Remote Similarity |
NPD2230 |
Approved |
0.6815
|
Remote Similarity |
NPD1481 |
Phase 2 |